Antipsychotic medication in first-episode psychosis: An RCT to assess the risk-benefit ratio [ 2014 - 2018 ]

Research Grant

Researchers: Prof Patrick Mcgorry (Principal investigator) ,  A/Pr Alexander Fornito ,  A/Pr C. Barnaby Nelson ,  A/Pr Mario Alvarez-Jimenez ,  Dr Kelly Allott
View all 7 related researchers

Brief description There has been an increasing emphasis on intervening early in psychotic disorders. A fundamental principle in early intervention is “to do no harm” and benefits must outweigh the risks of treatment. While antipsychotic medication is very effective and evidence-based form of treatment for positive symptoms in most first episode psychosis (FEP) patients it has risks. This study has the potential to determine whether antipsychotic medication should be the initial treatment option for FEP.

Funding Amount $AUD 1,141,117.06

Funding Scheme Project Grants

Notes Standard Project Grant